Author network for Elin H. Kure by COREMINE medical

Publications 2012

Hamfjord J, Stangeland AM, Hughes T, Skrede ML, Tveit KM, Ikdahl T, Kure EH (2012)
Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing
PLoS One, 7 (4), e34150
PubMed 22529906

Kjersem JB, Ikdahl T, Guren T, Skovlund E, Sorbye H, Hamfjord J, Pfeiffer P, Glimelius B, Kersten C, Solvang H, Tveit KM, Kure EH (2012)
Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
BMC Cancer, 12, 534
PubMed 23167843

Kure EH, Hamfjord J, Stangeland AM, Tveit KM, Ikdahl T (2012)
KRAS mutational test for metastatic colorectal cancer patients: not just a technical problem
Expert Rev Mol Diagn, 12 (4), 327-8
PubMed 22616697

Tveit KM, Guren T, Glimelius B, Pfeiffer P, Sorbye H, Pyrhonen S, Sigurdsson F, Kure E, Ikdahl T, Skovlund E, Fokstuen T, Hansen F, Hofsli E, Birkemeyer E, Johnsson A, Starkhammar H, Yilmaz MK, Keldsen N, Erdal AB, Dajani O, Dahl O, Christoffersen T (2012)
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study
J Clin Oncol, 30 (15), 1755-62
PubMed 22473155

Publications 2011

Bornholdt J, Friis S, Godiksen S, Poulsen SS, Santoni-Rugiu E, Bisgaard HC, Lothe IM, Ikdahl T, Tveit KM, Johnson E, Kure EH, Vogel LK (2011)
The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
BMC Cancer, 11, 65
PubMed 21310043

Hamfjord J, Stangeland AM, Skrede ML, Tveit KM, Ikdahl T, Kure EH (2011)
Wobble-enhanced ARMS method for detection of KRAS and BRAF mutations
Diagn Mol Pathol, 20 (3), 158-65
PubMed 21817902

Marcos NT, Bennett EP, Gomes J, Magalhaes A, Gomes C, David L, Dar I, Jeanneau C, DeFrees S, Krustrup D, Vogel LK, Kure EH, Burchell J, Taylor-Papadimitriou J, Clausen H, Mandel U, Reis CA (2011)
ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues
Front Biosci (Elite Ed), 3, 1443-55
PubMed 21622148

Skjelbred CF, Svendsen M, Haugan V, Eek AK, Clausen KO, Kure EH, Tuimala JT, Svendsen MV, Norppa H, Hansteen IL (2011)
Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes
Carcinogenesis, 32 (3), 399-405
PubMed 21097530

Publications 2009

Andersen V, Agerstjerne L, Jensen D, Østergaard M, Saebø M, Hamfjord J, Kure E, Vogel U (2009)
The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study
BMC Med Genet, 10, 18
PubMed 19250544

Hansteen IL, Clausen KO, Haugan V, Svendsen M, Svendsen MV, Eriksen JG, Skiaker R, Hauger E, Lågeide L, Vistnes AI, Kure EH (2009)
Cytogenetic effects of exposure to 2.3 GHz radiofrequency radiation on human lymphocytes in vitro
Anticancer Res, 29 (11), 4323-30
PubMed 20032374

Hansteen IL, Lågeide L, Clausen KO, Haugan V, Svendsen M, Eriksen JG, Skiaker R, Hauger E, Vistnes AI, Kure EH (2009)
Cytogenetic effects of 18.0 and 16.5 GHz microwave radiation on human lymphocytes in vitro
Anticancer Res, 29 (8), 2885-92
PubMed 19661291

Selzer-Plon J, Bornholdt J, Friis S, Bisgaard HC, Lothe IM, Tveit KM, Kure EH, Vogel U, Vogel LK (2009)
Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis
BMC Cancer, 9, 201
PubMed 19555470

Skovbjerg H, Anthonsen D, Lothe IM, Tveit KM, Kure EH, Vogel LK (2009)
Collagen mRNA levels changes during colorectal cancer carcinogenesis
BMC Cancer, 9, 136
PubMed 19422682

Publications 2008

Saebø M, Skjelbred CF, Brekke Li K, Bowitz Lothe IM, Hagen PC, Johnsen E, Tveit KM, Kure EH (2008)
CYP1A2 164 A-->C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas
Anticancer Res, 28 (4C), 2289-95
PubMed 18751408

Publications 2007

Lorentzen A, Vogel LK, Lewinsky RH, Saebø M, Skjelbred CF, Godiksen S, Hoff G, Tveit KM, Lothe IM, Ikdahl T, Kure EH, Mitchelmore C (2007)
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma
BMC Cancer, 7, 192
PubMed 17935612

Skjelbred CF, Saebø M, Hjartåker A, Grotmol T, Hansteen IL, Tveit KM, Hoff G, Kure EH (2007)
Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas
BMC Cancer, 7, 228
PubMed 18093316

Publications 2006

Saebø M, Skjelbred CF, Nexø BA, Wallin H, Hansteen IL, Vogel U, Kure EH (2006)
Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas
BMC Cancer, 6, 208
PubMed 16914027

Sarebø M, Skjelbred CF, Breistein R, Lothe IM, Hagen PC, Bock G, Hansteen IL, Kure EH (2006)
Association between cigarette smoking, APC mutations and the risk of developing sporadic colorectal adenomas and carcinomas
BMC Cancer, 6, 71
PubMed 16545110

Skjelbred CF, Saebø M, Nexø BA, Wallin H, Hansteen IL, Vogel U, Kure EH (2006)
Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control study
BMC Cancer, 6, 175
PubMed 16817948

Skjelbred CF, Saebø M, Wallin H, Nexø BA, Hagen PC, Lothe IM, Aase S, Johnson E, Hansteen IL, Vogel U, Kure EH (2006)
Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study
BMC Cancer, 6, 67
PubMed 16542436

Vogel LK, Saebø M, Skjelbred CF, Abell K, Pedersen ED, Vogel U, Kure EH (2006)
The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals
BMC Cancer, 6, 176
PubMed 16820046

Publications 2005

Hansen R, Saebø M, Skjelbred CF, Nexø BA, Hagen PC, Bock G, Bowitz Lothe IM, Johnson E, Aase S, Hansteen IL, Vogel U, Kure EH (2005)
GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer
Cancer Lett, 229 (1), 85-91
PubMed 15946795

Stormorken AT, Bowitz-Lothe IM, Norèn T, Kure E, Aase S, Wijnen J, Apold J, Heimdal K, Møller P (2005)
Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer
J Clin Oncol, 23 (21), 4705-12
PubMed 16034045

Publications 2004

Soucek P, Skjelbred CF, Svendsen M, Kristensen T, Kure EH, Kristensen VN (2004)
Single-track sequencing for genotyping of multiple SNPs in the N-acetyltransferase 1 (NAT1) gene
BMC Biotechnol, 4, 28
PubMed 15563733

Publications 2001

Kristensen VN, Kure EH, Erikstein B, Harada N, Børresen-Dale A (2001)
Genetic susceptibility and environmental estrogen-like compounds
Mutat Res, 482 (1-2), 77-82
PubMed 11535251

Publications 2000

Skaug V, Ryberg D, Kure EH, Arab MO, Stangeland L, Myking AO, Haugen A (2000)
p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients
Clin Cancer Res, 6 (3), 1031-7
PubMed 10741731

Publications 1997

Hollstein M, Bartsch H, Wesch H, Kure EH, Mustonen R, Mühlbauer KR, Spiethoff A, Wegener K, Wiethege T, Müller KM (1997)
p53 gene mutation analysis in tumors of patients exposed to alpha-particles
Carcinogenesis, 18 (3), 511-6
PubMed 9067550

Kure EH, Andreassen A, Ovrebø S, Grzybowska E, Fiala Z, Strózyk M, Chorazy M, Haugen A (1997)
Benzo(a)pyrene-albumin adducts in humans exposed to polycyclic aromatic hydrocarbons in an industrial area of Poland
Occup Environ Med, 54 (9), 662-6
PubMed 9423579

Publications 1996

Andreassen A, Kure EH, Nielsen PS, Autrup H, Haugen A (1996)
Comparative synchronous fluorescence spectrophotometry and 32P-postlabeling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutations
Mutat Res, 368 (3-4), 275-82
PubMed 8692233

Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A (1996)
p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels
Carcinogenesis, 17 (10), 2201-5
PubMed 8895489

Publications 1995

Ovrebø S, Fjeldstad PE, Grzybowska E, Kure EH, Chorazy M, Haugen A (1995)
Biological monitoring of polycyclic aromatic hydrocarbon exposure in a highly polluted area of Poland
Environ Health Perspect, 103 (9), 838-43
PubMed 7498096

Publications 1994

Ryberg D, Kure E, Lystad S, Skaug V, Stangeland L, Mercy I, Børresen AL, Haugen A (1994)
p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer
Cancer Res, 54 (6), 1551-5
PubMed 8137262

Publications 1991

Rappaport SM, Kure E, Petreas M, Ting D, Woodlee J (1991)
A field method for measuring solvent vapors in exhaled air--application to styrene exposure
Scand J Work Environ Health, 17 (3), 195-204
PubMed 2068559